Combinatorial effects of conception and governor vessel electroacupuncture and human umbilical cord blood-derived mesenchymal stem cells on pathomorphologic lesion and cellular apoptosis in rats with cerebral ischemia/reperfusion  by Yang, Zhuoxin et al.
TOPIC
JTCM |www. journaltcm. com December 15, 2013 |Volume 33 | Issue 6 |
Online Submissions: http://www.journaltcm.com J Tradit Chin Med 2013 December 15; 33(6): 779-786
info@journaltcm.com ISSN 0255-2922
© 2013 JTCM. All rights reserved.
EXPERIMENTAL STUDY
Combinatorial effects of conception and governor vessel electroacu-
puncture and human umbilical cord blood-derived mesenchymal
stem cells on pathomorphologic lesion and cellular apoptosis in
rats with cerebral ischemia/reperfusion
Zhuoxin Yang, Pengdian Chen, Haibo Yu, Wenshu Luo, Min Pi, Yonggang Wu, Ling Wang, Fuxia Yang, Yanhua
Gou
aa
Zhuoxin Yang, Department of Traditional Chinese Medi-
cine, Affiliated Shenzhen Maternity & Child Healthcare Hos-
pital, Southern Medical University, Shenzhen 518028, China
Pengdian Chen, Haibo Yu, Wenshu Luo, Min Pi, Yong-
gang Wu, Ling Wang, Fuxia Yang, Yanhua Gou, Depart-
ment of Acupuncture & Moxibustion, Affiliated Shenzhen
Traditional Chinese Medicine Hospital, Guangzhou Universi-
ty of Chinese Medicine, Shenzhen 518033, China
Supported by the National Natural Science Foundation of
China (No. 81072877); Shenzhen Municipal Science and
Technology Research Development and Funds and Platform
Construction Plan Key Laboratory Program (No.
CXB201111250113A); Shenzhen Municipal Science and
Technology Plan Project (No. 201203149)
Correspondence to: Prof. Haibo Yu, Affiliated Shenzhen
Traditional Chinese Medicine Hospital, Guangzhou Universi-
ty of Chinese Medicine, Shenzhen 518033, China. szmed-
bm@yahoo.com.cn
Telephone: +86-13603066098
Accepted:May 16, 2013
Abstract
OBJECTIVE: To investigate the combinatorial ef-
fects of conception and governor vessel electroacu-
puncture (EA) and human umbilical cord blood-de-
rived mesenchymal stem cells (HUCB-MSCs) on
pathomorphologic lesion and cellular apoptosis in
rats with cerebral ischemia/reperfusion.
METHODS:With the HUCB-MSCs isolated, cultured
and identified and the models of cerebral isch-
emia-reperfusion established, the HUCB-MSCs of
passage three were intracranially transplanted and
the EA at conception and governor vessels was ap-
plied. The pathomorphologic lesion by hematoxy-
lin-eosin staining and the cellular apoptosis by ter-
minal deoxynucleotidyl transferase-mediated
nick-end labeling method around the ischemic fo-
cus were observed.
RESULTS: The cultured adherent HUCB-MSCs ex-
hibited a spindle shape and expressed MSC-specif-
ic markers, with the cell purity and proliferation
rate significantly increasing after the primary pas-
sage. HE staining showed that there were no patho-
logical changes observed in the sham surgery
group. However, in the PBS transplantation group,
degeneration and necrosis of a great number of
nerve cells were seen. In both the HUCB-MSCs
transplantation group and the HUCB-MSCs trans-
plantation + EA group, reparative changes of the
pathomorphism of the tissue were found. Both
combination treatment and simple MSCs treat-
ment were able to improve the pathomorphorlogic
lesion following cerebral ischemia and reduce the
abnormal TUNEL-positive numbers, with former
better than latter.
CONCLUSION: HUCB-MSCs improve pathological
lesions and inhibit the cellular apoptosis around
the cerebral ischemic area. EA at conception and
governor vessels also improve pathological lesion
and inhibit the cellular apoptosis in rats treated
with HUCB-MSCs transplantation, which effects
were superior to that of simple HUCB-MSCs trans-
plantation.
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INTRODUCTION
Stroke, the third most frequent cause of morbidity,
mortality and disability in industrialized countries, can
be catastrophic for the afflicted individual.1,2 In recent
years, mesenchymal stem cells (MSCs) transplantation
has emerged as an attractive and promising novel thera-
peutic option in treatment of stroke in experimental
studies,2 and several hypotheses to account for the ame-
lioration of neurological outcome have been suggested,
including attenuation of neuroinflammation, secretion
or stimulation of trophic factors and cytokines, and in-
hibition of cellular apoptosis, etc.3-5 Acupuncture has
been widely applied in treating stroke for thousands of
years in China. In our previous experimental works,
conception and governor vessel electroacupuncture
(EA) continuously promotes the proliferation and dif-
ferentiation of endogenous neural stem cells (NSCs) in-
to neurons,6 and Conception Vessel EA up-regulates
the neurotrophic factor expressions,7 which consequent-
ly might protects the neurons from apoptosis and is
beneficial for the nerve regeneration.8 Resent studies
on cerebral ischemia models have also shown that Gov-
ernor Vessel acupuncture accelerates functional recov-
ery and reduces infarct volume,9 ameliorates ischemic
neuronal damage,10 up-regulates neurotrophic factor ex-
pressions11 and inhibits the neuronal apoptosis.12 Tak-
ing these finding together, conception and governor
vessel EA has the similar actions with the MSCs trans-
plantation, which might perform anti-apoptotic effects
via diverse pathways.
To investigate the combinatorial effects of EA and
MSCs in the treatment of cerebral ischemia/reperfu-
sion, human umbilical cord blood-derived mesenchy-
mal stem cells (HUCB-MSCs) were isolated, cultured
and transplanted into the brains of cerebral ischemia/
reperfusion rats and the EA was applied to examine
their combinatorial effects on the pathomorphologic le-
sion by hematoxylin-eosin (HE) staining and neuronal
apoptosis by terminal deoxynucleotidyl transferase-me-
diated dUTP nick-end labeling (TUNEL) method in
the rats, which may introduce a novel approach for
stem cell therapy assisted by acupuncture to treat cere-
bral infarction.
MATERIALS ANDMETHODS
Drugs and reagents
Dulbecco's modified eagle's medium/nutrient mixture
F-12 (DMEM/F12), 10% fetal bovine serum (FBS),
1% glutamine and 0.25% trypsin-EDTA were pur-
chased from Gibco (Los Angeles, CA, USA). 100 U/
mL penicillin-streptomycin was purchased from Hy-
clone (Logan, UT, USA). 10 ng/mL human epidermal
growth factor (EGF) was purchased from ProSpec
(Ness-Ziona, Israel). 10 ng/mL recombinant human fi-
broblast growth factor-basic (bFGF) was purchased
from PeproTech (New Jersey, USA). Antibodies CD73,
CD29, CD34, CD90, CD14, CD44, CD45, CD19,
CD105 and human leukocyte antigen (HLA)-DR were
purchased from Becton Dickinson (BD Biosciences,
San Diego, CA, USA). In situ cell death detection kit
was purchased from Merck (Darmstadt, Germany).
Blood samples and animal grouping
This study was approved by the Institutional Review
Board of Affiliated Shenzhen Traditional Chinese Med-
icine Hospital, Guangzhou University of Chinese Med-
icine. HUCB samples were collected from umbilical
veins after neonatal delivery, with informed consent
from pregnant mothers. A total of 96 adult, male, spe-
cific pathogen-free SD rats, weighing 220-250 g were
provided by Guangdong Provincial Experimental Ani-
mal Center, Guangdong, China (license No. SCXK
(Yue) 2008-0002). All experimental protocol and pro-
cedures were performed in accordance with the Guid-
ance Suggestions for the Care and Use of Laboratory
Animals, formulated by the Ministry of Science and
Technology of China.13 The 96 SD rats were random-
ized into sham surgery group, phosphate-buffered sa-
line (PBS) transplantation group, HUCB-MSCs trans-
plantation group and HUCB-MSCs transplantation +
EA group (n=24). In terms of the time period after ce-
rebral ischemia/reperfusion, each group could be fur-
ther divided into three subgroups of 7, 14 and 28 days.
Isolation, cultivation, identification and growth
curve of HUCB-MSCs
HUCB mononuclear cells (MNCs) were isolated with
the density gradient centrifugation method described
previously.14 After centrifugation, the serum was slowly
added into the upper layer of lymphocyte separation
medium with a specific gravity of 1.077 g/cm3 in the
volume of 2∶1. After horizontal centrifugation at 750 ×
g for 22 min, the MNC layer was carefully sucked and
added with PBS of 3-5-fold volume, centrifugalized at
200 ×g for 10 min, washed twice, and then the super-
natant was discarded. Finally, the MNCs were adjusted
as 1×106/cm2 and seeded in a T-75 plastic culture flask
with DMEM/F12, containing 10% FBS, 100 U/mL
penicillin-streptomycin, 1% glutamine, 10 ng/mL hu-
man EGF and 10 ng/mL recombinant human bFGF,
etc, which was placed in a humidified atmosphere con-
taining 5% CO2 at 37℃ . MSCs, which selected by
plastic adhesion, require the elimination of non-adher-
ent cells by replacing the medium 7 d after cell seed-
ing, and afterwards, the medium was completely re-
placed with the same fresh medium every three days,
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and then cellular morphological changes were observed
and recorded under an inverted microscope. When cul-
tures almost reached approximately 80% confluence,
the adherent cells were trypsinized with 0.25% tryp-
sin-EDTA and passed, with the medium completely re-
placed once every third day. The third passage cells of
human umbilical cord blood harvests were used for the
experimental work, with the final concentration as 1×
105/ μL for the transplantation.
For the identification, HUCB-MSCs of the primary
passage were collected, counted and analyzed by flow
cytometry with antibodies to CD73, CD29, CD34,
CD90, CD14, CD44, CD45, CD19, CD105 and
HLA-DR. MSCs removed from the culture flask were
washed with PBS twice and then treated with phycoer-
ythrin (PE), fluorescein isothiocyanate (FITC), allophy-
cocyanion (APC) or Peridinin-Chlorophyll-Protein
Complex (PerCP)-conjugated monoclonal antibodies
for half an hour, and then washed again and examined
for fluorescence.
For HUCB-MSCs growth curves, the third passage of
the cells was trypsinized with 0.25% trypsin-EDTA
and incubated in the same DMEM/F12. Cell density
was adjusted to 3000 cells/well. Subsequently,
HUCB-MSCs were seeded into a total of two 24-well
plates. A total of 12 wells/plate were used. After 24,
48, 72, 96, 120 h, etc, of incubating in a culture of
37℃ in a 5% CO2 incubator, cells of one well in each
plate were digested and counted, respectively. Experi-
mentation lasted for 12 consecutive days, and the cell
growth curves were calculated.
Establishment of focal cerebral ischemia-reperfusion
model
Thread embolism-induced occlusion of the middle ce-
rebral artery was applied to establish a model of cere-
bral ischemia/reperfusion as we previously described.15
In brief, rats were initially intraperitoneally anesthe-
tized with a 10% chloral hydrate (300 mg/kg). By us-
ing a surgical microscope (STEMI DV4, New York,
NY, USA), the right external carotid artery (ECA) was
surgically exposed and clamped, a small incision was
made on the ECA and a length of 30 mm 4-0 monofil-
ament suture with the tip rounded by heating near a
flame was advanced from it into the lumen of the inter-
nal carotid artery (ICA) with the depth of (18±2) mm,
until it blocked the origin of the middle cerebral artery.
After 2 h, the suture was withdrawn out of ICA to re-
store the blood flow and the muscle and skin in layers
was sutured. For the sham surgery group, the operating
procedure was the same as described above without fila-
ment insertion into the ICA.
Intracranial transplantation
Referring to the intracranial transplantation method
described previously,16 the next day of model establish-
ment, rats were anesthetized and placed in a stereotac-
tic apparatus (world precision instruments, Inc, Saraso-
ta, FL, USA). An incision was made exposing bregma.
A burr hole was made using a small high-speed dental
drill, and a suspension of 10 μL cell with a total of 106
HUCB-MSCs at the right striatum (AP=0 mm, ML=
2.0 mm, DV=4.5 mm) and right subcortex (AP=
0 mm, ML=2.0 mm, DV=2.0 mm) using a 25 μL Mi-
crosyringe (Hamilton, Switzerland) was injected stereo-
tactically, with 7 μL at the striatum and 3 μL at the
subcortex. Cells were injected at the speed of 1 μL/min
and placed for another 5 min thereafter. Equal volume
of PBS was administered in the PBS transplantation
group with the same procedure.
EA treatment
The acupoints of Shuigou (GV 26), Baihui (GV 20)
and Dazhui (GV 14) from Governor Vessel and
Chengjiang (CV 24), Guanyuan (CV 4) and Qihai
(CV 6) from Conception Vessel were selected accord-
ing to document.17 Shuigou (GV 26) is located 1 mm
below nasal tip, Baihui (GV 20) is located at the center
of parietal bone, Dazhui (GV 14) is located below the
spinous process of the 7th cervical and 1st thoracic ver-
tebrae, Chengjiang (CV 24) is located 1 mm below pu-
bic margin of low lip, Guanyuan (CV 4) is located
25 mm below the umbilicus, and Qihai (CV 6) is locat-
ed at the middle point between umbilicus and Guanyu-
an (CV 4). A 0.3 mm × 25 mm needle (Suzhou Acu-
puncture Supplies, Suzhou, China) was inserted into
Shuigou (GV 26) approximately 1 mm upward, Baihui
(GV 20) 4 mm backward, Chengjiang (CV 24) 1 mm
downward and Dazhui (GV 14), Guanyuan (CV 4)
and Qihai (CV 6) 5 mm vertically, respectively. The
acupoints were stimulated with EA (type SDZ-II elec-
tric acupuncture apparatus, Suzhou Medical Appliance
Factory, Suzhou, China), with the frequency of 30 Hz
disperse waves and 100 Hz dense waves and 5V intensi-
ty for 20 min, QD.
Pathomorphologic analysis
Seven days after model establishment, rats in the 7-day
group were deeply anesthetized and transcardially per-
fused with 120 mL PBS followed by 400 mL of freshly
prepared solution consisting of 4% paraformaldehyde
in 0.1 M phosphate buffer (PB, pH 7.4). Brains were
harvested and immersed in 4% paraformaldehyde in
PBS for 2 days prior to paraffin embedding. Following
slicing, a series of adjacent 3-μm-thick sections were
cut in the coronal plane and were counterstained with
HE and observed the pathomorphologic difference un-
der light microscopy.
Apoptotic cell staining
TUNEL assay was performed using an In Situ Cell
Death Detection Kit according to the manufacturer's
instructions. TUNEL method is based on the specific
binding of deoxynucleotidyltransferase (TdT) to
3'-OH ends of DNA and the ensuing synthesis of poly-
deoxynucleotide polymer cells. In brief, after deparaf-
finizing brain sections and digesting protein using pro-
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teinase K (20 μg/mL) and then quenching endogenous
peroxidase activity with 3% H2O2 in PBS, sections
were incubated with the terminal TdT buffer for
30 min at 37℃ . The TdT buffer was discarded, re-
placed by fresh buffer (60 μL) containing 57 μL bio-
tin-FragELTM labeling reaction mix and 3 μL TdT en-
zyme, and then allowed to incubate for 90 min at 37℃
followed by washing the slides three times each for 5 min
in PBS to terminate the reaction. The incorporated bio-
tin-dUTP was detected by the avidin-biotinglated en-
zyme complex followed by 3, 3-diaminobenzidine sub-
strate. Sections were counterstained with methylgreen
and photographed. The labeling target of the TUNEL
method was the new 3'-OH DNA ends generated by
DNA fragmentation, which were typically located in
morphologically identificable nuclei and apoptotic bod-
ies with dark brown, rounded or oval bodies.
Statistical analysis
Data were expressed as mean±standard deviation (SD).
SPSS 15.0 (SPSS, Chicago, IL, USA) for Windows
software was used to perform one-way analysis of vari-
ance. For homogeneity variance, the least significant
difference t-test was used, and a level of P<0.05 was
considered statistically significant. For non-homogene-
ity variance, the Cochran & Cox similar t-test was
used, and a level of P<0.05 was considered statistical-
ly significant.
RESULTS
Morphology, identification and growth curve of
HUCB-MSCs
After 1 week of seeding, non-adherent cells were
washed and removed, and the adherent HUCB-MSCs
were scattered in a number of colony distributions. Af-
ter about 3 weeks, there were mostly bipolar spin-
dle-like cells with a whirl pool-like array and the cells
were passaged when cultures almost reached approxi-
mately 80% confluence. At day 1-2 of passage, the bot-
tle was covered with long-spindle cells, which were uni-
formly distributed and covered the bottle every 5-7
days (Figure 1).
According to the standards of identification of MSCs
proposed by the International Society for Cellular
Therapy,18 we selected the specific cell surface markers
to identify the cells cultured. The results confirmed
that the cell population of the primary passage (P0) ob-
tained from HUCB were characterized with flow cy-
tometry and highly expressed mesenchymal antigens,
including CD90 (100%), CD73 (83.4%) and CD105
(99.8%), and adhesion molecules CD44 (100%) and
CD29 (94.9% ), but expressed low levels of CD45
(1.1%), CD34 (1.2%), CD19 (1.4%), CD14 (1.1%)
and HLA-DR (0.7% ), which indicated that major
population of the adherent cells cultured were MSCs.
(Figure 2).
To determine the cellular proliferation, we took the ad-
herent cells of passage three for the growth test. Results
from the growth curve measurement showed that the
logarithmic growth phase of the cells was 2-3 days,
with a plateau phase at 4-5 days, and an apoptosis
phase after day 5 (Figure 3).
Combinatorial effects of EA and HUCB-MSCs on
pathomorphologic lesion of the cerebral ischemic
boundary zone
Results from the HE staining indicated that in the
sham surgery group, the structure and form of the
nerve cells were normal, with round or oval nuclei, ob-
vious nuclei and nucleoli. There was no red-staining of
cytoplasm or edema of cells and intercellular substance.
In the PBS transplantation group, degeneration and ne-
crosis of a great number of nerve cells, with cell body
shrinking, poor nuclear staining, pyknosis and karyoly-
sis in neurons, concentrated cytoplasm and red-stain-
ing, obvious edema of intercellular substance, infiltra-
tion of leukocytes, even some vacuolization of neurons
resulting from neuronal loss and tissue disintegration
were seen under the light microscope. In both the
HUCB-MSCs transplantation group and the
HUCB-MSCs transplantation+EA group, hemosidero-
sis was found, small vessels were proliferated and the
number of degenerative and necrotic nerve cells was re-
duced with the degree of edema obviously alleviated,
which suggested reparative pathological changes of the
tissue (Figure 4).
Combinatorial effects of EA and HUCB-MSCs on
cellular apoptosis in the cerebral ischemic boundary
zone
TUNEL staining showed apoptotic cells with typical
CBA
Figure 1 Morphology of HUCB-MSCs (×100)
A: Day 12 of primary passage; B: Day 1 of passage 1; C: Day 4 of passage 1. HUCB-MSCs: human umbilical cord blood-derived mes-
enchymal stem cells.
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dark brown, rounded or oval apoptotic bodies, which
were frequently observed in the ischemic penumbra
(Figure 5).
No significant differences in the number of positive
cells were found between the various time points in the
sham surgery group. However, the apoptotic cells were
frequently obtained in the ischemic penumbra in other
groups and the numbers had the tendency of decreas-
ing, which were highest at 7 days and significantly de-
creased by 14 days and were lowest at 28 days (P<
0.01). There was a great number of apoptotic cells at 7,
14 and 28 days after PBS transplantation in the PBS
transplantation group, compared with those in the oth-
er three groups (P<0.01). At day 7, there were less
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apoptotic cells in the HUCB-MSCs transplantation +
EA group compared with those in the HUCB-MSCs
transplantation group with significant difference (P<
0.01), and with the prolonging of the reperfusion peri-
od, the situation was the same at 14 and 28 days (P<
0.01) (Figure 6).
DISCUSSION
MSCs are highly attractive candidates for the treat-
ment of cerebral ischemia/reperfusion to regenerate
damaged neurons since they self-renew with a high pro-
liferative capacity, secrete diverse neurotrophic factors
and inhibit cellular apoptosis.19,20 Among them,
HUCB-MSCs have proven to be more advantageous
than bone marrow-derived MSCs in terms of cell pro-
curement, storage and transplantation.21 In addition, the
number and differentiation ability of bone marrow-de-
rived MSCs significantly decrease with age, and HUCB
is abundant in adult stem and progenitor cells,22,23 which
make HUCB-MSCs potent candidates for the clinical
application of MSC-based therapy. Hence, in the pres-
ent study, we selected the HUCB as the source of the
MSCs.
Results from the present study showed that the cul-
tured adherent HUCB-MSCs exhibited a spindle
shape and expressed MSC-specific markers, with the
cell purity and proliferation rate significantly increas-
ing after the primary passage. When cerebral ischemia/
reperfusion occurs, it exacerbates the dysfunction and
structure injury of the cerebral tissue, and the cells
within the boundary and central zones of ischemic le-
sions are highly vulnerable to necrosis and apoptosis.
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Figure 6 Effects of HUCB-MSCs plus EA on numbers of apop-
totic cells
A: sham surgery group, no ischemia/reperfusion; B: PBS
transplantation group, ischemia/reperfusion plus PBS trans-
plantation; C: HUCB-MSCs transplantation group, ischemia/
reperfusion plus HUCB-MSCs transplantation; D: HUCB-
MSCs transplantation + EA group, ischemia/reperfusion,
HUCB-MSCs transplantation and conception and governor
vessel EA. PBS: phosphate-buffered saline; HUCB-MSCs: hu-
man umbilical cord blood-derived mesenchymal stem cells;
EA: electroacupuncture. Data are presented as mean±SD (n=
8). In the same ischemic time, significant differences com-
pared with sham surgery group were designated as aP<0.01,
with PBS transplantation group as bP<0.01, and with
HUCB-MSCs transplantation group as cP<0.01.
A B C D
Figure 4 Pathological changes of ischemic boundary zone in four groups by HE staining (×100)
A: sham surgery group, no ischemia/reperfusion; B: PBS transplantation group, ischemia/reperfusion plus PBS transplantation; C:
HUCB-MSCs transplantation group, ischemia/reperfusion plus HUCB-MSCs transplantation; D: HUCB-MSCs transplantation+EA
group, ischemia/reperfusion, HUCB-MSCs transplantation and conception and governor vessel EA. HE: hematoxylin and eosin;
PBS: phosphate-buffered saline; HUCB-MSCs: human umbilical cord blood-derived mesenchymal stem cells; EA: electroacupunc-
ture.
A B C D
Figure 5 Cellular apoptosis in ischemic boundary zone in four groups by TUNEL staining at day 14 (×100)
A: sham surgery group, no ischemia/reperfusion; B: PBS transplantation group, ischemia/reperfusion plus PBS transplantation; C:
HUCB-MSCs transplantation group, ischemia/reperfusion plus HUCB-MSCs transplantation; D: HUCB-MSCs transplantation+EA
group, ischemia/reperfusion, HUCB-MSCs transplantation and conception and governor vessel EA. PBS: phosphate-buffered sa-
line; HUCB-MSCs: human umbilical cord blood-derived mesenchymal stem cells; EA: electroacupuncture; TUNEL: terminal deoxy-
nucleotidyl transferase-mediated nick-end labeling.
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Apoptosis, also known as programmed cell death, is a
form of delayed cell death that serves to eliminate dy-
ing cells in proliferating or differentiating cell popula-
tions, which is modulated by numerous factors includ-
ing ischemia, hypoxia, oxygen free radicals, Ca2 + over-
load in cells, etc.24 In addition, apoptosis participates in
the enlargement of the infarct area and might deter-
mine the cerebral ischemia volume in the ischemic pen-
umbra area, which appears to play a key role in neuro-
nal cell death following ischemic stroke.25,26 Apoptotic
cell death can be assessed by TUNEL staining, which is
a widely used method for the detection of DNA frag-
mentation, a characteristic of apoptotic cell death.27
Hence, in the present study, we selected the TUNEL
method for the detection of apoptotic cells.
Results from the present research indicated that EA
plus HUCB-MSCs transplantation has the synergetic
effects in the treatment of cerebral ischemia/reperfu-
sion, which could obviously protect the cerebral tissue
via alleviating the edema, accelerating vessel prolifera-
tion and inhibiting cellular apoptosis, etc, and the an-
ti-apoptotic action is stronger in the combination
group than that in the simple HUCB-MSCs transplan-
tation group. Of particular interest is these actions
mainly manifest in 7-28 days after reperfusion. Accord-
ing to Traditional Chinese Medicine theories, the con-
ception vessel is "the sea of Yin Vessels", which governs
embryonic pregnancy and controls growth and devel-
opment of the fetus and may enhance the expressions
of diverse endogenous neurotrophic factors to protect
the cerebral tissue. The governor vessel is "the sea of
Yang Vessels", which manages Yang Qi thereby govern-
ing and activating Yang Qi and may inhibit the cellular
apoptosis following the cerebral ischemia/reperfusion
injuries.28
In conclusion, we have shown that EA at conception
and governor vessels plus HUCB-MSCs transplanta-
tion suppressed the increment of the TUNEL-positive
cell number. Based on the results, it is possible that the
combinatorial effects on the pathological changes can
be ascribed to the inhibition of apoptotic neuronal cell
death by the combined treatments. Studies indicated
that MSCs following transplantation have the ability
to differentiate into neural-lineage and apoptosis is re-
lated to the caspase family, Bcl-2 family, nuclear fac-
tor-κb and other genes.14,29 More in-depth studies of
the relation between the cell apoptosis and the apopto-
sis-related gene expressions would be necessary to ascer-
tain whether EA plus MSCs could promote the trans-
planted MSCs differentiation into neuron-like cells via
anti-apoptotic effects.
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